GS1-144 drug study in women with liver problems
Part of Digestive system clinical trials.
This study tests a new drug called GS1-144 in women with mild or moderate liver problems and healthy women to see how the body handles the drug. It helps researchers understand if liver function affects the drug's safety and how it is processed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 18 and 70 years old.
- You must weigh at least 45 kg (about 99 pounds) and have a BMI between 18 and 32.
- You must have either normal liver function or mild to moderate liver impairment (called Child-Pugh A or B).
- If you have liver impairment, your liver-related medications must have been stable for at least 2 weeks, or you are not taking any.
- You must be willing to use effective birth control if you could become pregnant, and not be pregnant or breastfeeding.
- You cannot have used tobacco, alcohol, or certain medications within the past month or 3 months, respectively.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (MDR-001) in people with mild to moderate liver problems to see how the body processes it and if it's safe. It may help doctors find the right dose for patients with liver disease.
This study tests a new medicine for people with mild or moderate liver problems to see how the liver affects the drug in the body. It also includes people with normal liver function for comparison.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.
This study looks at how a new oral drug (called INCB161734) is processed by the body and how safe it is in people with liver problems. It may help doctors understand the right dose for patients with liver impairment.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
Hear when a new Hepatic Impairment and Healthy Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.